1 – 35 of 35
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Normalizing to GADPH jeopardises correct quantification of gene expression in ovarian tumours-IPO8 and RPL4 are reliable reference genes
(
- Contribution to journal › Article
- 2012
-
Mark
The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
(
- Contribution to journal › Article
-
Mark
High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer
(
- Contribution to journal › Article
- 2010
-
Mark
G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua.
(
- Contribution to journal › Article
- 2009
-
Mark
Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms.
(
- Contribution to journal › Article
-
Mark
Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.
(
- Contribution to journal › Article
-
Mark
Monoamine transporters in human endometrium and decidua.
(
- Contribution to journal › Article
- 2008
-
Mark
Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
The organic cation transporters (OCT1, OCT2, EMT) and the plasma membrane monoamine transporter (PMAT) show differential distribution and cyclic expression pattern in human endometrium and early pregnancy decidua.
(
- Contribution to journal › Article
-
Mark
Transvaginal ultrasound and lactate dehydrogenase isoenzyme activity profile in uterine aspirate for diagnosis of endometrial carcinoma in women with postmenopausal bleeding.
(
- Contribution to journal › Article
- 2006
-
Mark
Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients.
(
- Contribution to journal › Article
-
Mark
Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid.
(
- Contribution to journal › Article
-
Mark
Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2
(
- Contribution to journal › Article
-
Mark
Implantation of the human embryo: Research lines and models
(
- Contribution to journal › Scientific review
-
Mark
EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
(
- Contribution to journal › Article
- 2005
-
Mark
LD-isoenzym i uterusaspirat potentiell markör för endometriecancer. Utredning av postmenopausal blödning kan bli enklare och billigare
(
- Contribution to journal › Article
-
Mark
MMP-26 mRNA and estrogen receptor alpha co-expression in normal and pathological endometrium
(
- Contribution to journal › Article
- 2004
-
Mark
Diagnosis of endometrial cancer in patients with postmenopausal bleeding by analysis of the lactate dehydrogenase isoenzyme activity profile in uterine fluid.
(
- Contribution to journal › Article
-
Mark
Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
(
- Contribution to journal › Article
-
Mark
Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
(
- Contribution to journal › Article
-
Mark
Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
(
- Contribution to journal › Article
-
Mark
Nove matrix metaloproteinazy v cyklickem endometriu
(
- Contribution to journal › Article
-
Mark
Exprese MMP-26 v endometrialnich explantech pod vlivem estradiolu a progesteronu
(
- Contribution to journal › Article
-
Mark
Profily endometrialni exprese mRNA u vybranych matrix metaloproteinaz a tkanoveho inhibitoru metaloproteinaz-1
(
- Contribution to journal › Article
-
Mark
Norepinephrine Transporter (NET), Serotonin Transporter (SERT), Vesicular Monoamine Transporter (VMAT2) and Organic Cation Transporters (OCT1, 2 and EMT) in Human Placenta from Pre-eclamptic and Normotensive Pregnancies.
(
- Contribution to journal › Article
- 2003
-
Mark
Plasma membrane and vesicular monoamine transporters in normal endometrium and early pregnancy decidua.
(
- Contribution to journal › Article
-
Mark
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
(
- Contribution to journal › Article
-
Mark
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer
(
- Contribution to journal › Article
-
Mark
Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium
(
- Contribution to journal › Article
- 2002
-
Mark
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
(
- Contribution to journal › Article
- 2001
-
Mark
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
(
- Contribution to journal › Article
-
Mark
Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
- 1998
-
Mark
High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
(
- Contribution to journal › Article
- 1981
-
Mark
Proteinases and proteinase inhibitors in uterine fluid, with special reference to IUD-users
1981) In Acta obstetricia et gynecologica Scandinavica. Supplement, 0300-8835 ; 98(
- Thesis › Doctoral thesis (compilation)